Description
Biosimilars and Interchangeable Biologics: Strategic Elements is an authoritative resource that examines the multifaceted aspects of developing, manufacturing, and bringing biosimilar drugs to market. The book covers critical topics including regulatory pathways, quality assurance, clinical development strategies, and intellectual property considerations that are vital for success in this rapidly evolving field.
Author Sarfaraz K. Niazi draws on extensive industry experience to provide practical guidance on navigating the complexities of biosimilar development. The text addresses both scientific and business dimensions, offering strategic insights for pharmaceutical companies, regulatory professionals, and healthcare stakeholders seeking to understand interchangeable biologics and their impact on the global healthcare market.
Reviews
There are no reviews yet.